Posters Overview
Human hepatocytes represent the optimal in vitro metabolism model as they express the comprehensive complement of drug-metabolizing enzymes. However, identifying the specific enzyme(s) driving the clearance of a drug candidate within this complex system remains challenging. Elucidating these pathways early in the lead optimization phase is crucial for predicting human clearance and mitigating drug-drug interaction (DDI) risks.

Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.